{
  "database_name": "PharmaSight\u2122 Research Article Database",
  "description": "Public database of all research articles scanned by autonomous research engine",
  "created": "2025-11-10T19:45:38.668523",
  "last_updated": "2025-11-10T19:47:52.332774",
  "total_articles": 26,
  "articles": [
    {
      "article_id": "ART-00001",
      "title": "Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms",
      "authors": [
        "Carhart-Harris RL",
        "Bolstridge M",
        "Day CMJ",
        "Rucker J",
        "Watts R"
      ],
      "doi": "10.1038/s41598-017-13282-7",
      "pmid": null,
      "journal": "Scientific Reports",
      "year": 2017,
      "abstract": null,
      "url": null,
      "keywords": [
        "psilocybin",
        "depression",
        "fMRI",
        "5-HT2A receptor"
      ],
      "relevance_score": 95.0,
      "scan_date": "2025-11-10T19:45:38.668573",
      "source_database": "PubMed",
      "research_goal": "Novel 5-HT2A Partial Agonist Discovery for Treatment-Resistant Depression",
      "added_to_database": "2025-11-10T19:45:38.668575"
    },
    {
      "article_id": "ART-00002",
      "title": "Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression",
      "authors": [
        "Zarate CA Jr",
        "Singh JB",
        "Carlson PJ",
        "Brutsche NE",
        "Ameli R"
      ],
      "doi": "10.1176/appi.ajp.2006.05081283",
      "pmid": "16816223",
      "journal": "American Journal of Psychiatry",
      "year": 2006,
      "abstract": null,
      "url": null,
      "keywords": [
        "ketamine",
        "NMDA",
        "depression",
        "rapid antidepressant"
      ],
      "relevance_score": 98.0,
      "scan_date": "2025-11-10T19:45:38.668582",
      "source_database": "PubMed",
      "research_goal": "NMDA Receptor Subtype-Selective Antagonist for Rapid Antidepressant Action",
      "added_to_database": "2025-11-10T19:45:38.668583"
    },
    {
      "article_id": "ART-00003",
      "title": "MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study",
      "authors": [
        "Mitchell JM",
        "Bogenschutz M",
        "Lilienstein A",
        "Harrison C",
        "Kleiman S"
      ],
      "doi": "10.1038/s41591-021-01336-3",
      "pmid": "33972795",
      "journal": "Nature Medicine",
      "year": 2021,
      "abstract": null,
      "url": null,
      "keywords": [
        "MDMA",
        "PTSD",
        "psychotherapy",
        "serotonin",
        "oxytocin"
      ],
      "relevance_score": 92.0,
      "scan_date": "2025-11-10T19:45:38.668588",
      "source_database": "PubMed",
      "research_goal": "Entactogen Development for PTSD Treatment",
      "added_to_database": "2025-11-10T19:45:38.668590"
    },
    {
      "article_id": "ART-00004",
      "title": "Kava lactones and the kava-kava controversy",
      "authors": [
        "Teschke R",
        "Sarris J",
        "Schweitzer I"
      ],
      "doi": "10.1016/j.phymed.2011.07.005",
      "pmid": null,
      "journal": "Phytomedicine",
      "year": 2011,
      "abstract": null,
      "url": null,
      "keywords": [
        "kava",
        "kavain",
        "anxiolytic",
        "GABA",
        "safety"
      ],
      "relevance_score": 88.0,
      "scan_date": "2025-11-10T19:45:38.668594",
      "source_database": "PubMed",
      "research_goal": "Novel Anxiolytic Development from Natural Products",
      "added_to_database": "2025-11-10T19:45:38.668595"
    },
    {
      "article_id": "ART-00005",
      "title": "Muscimol as a potent and selective orthosteric agonist of GABAA receptors",
      "authors": [
        "Johnston GA"
      ],
      "doi": "10.1111/j.1476-5381.2012.02144.x",
      "pmid": null,
      "journal": "British Journal of Pharmacology",
      "year": 2013,
      "abstract": null,
      "url": null,
      "keywords": [
        "muscimol",
        "GABA-A",
        "agonist",
        "anxiolytic",
        "sleep"
      ],
      "relevance_score": 90.0,
      "scan_date": "2025-11-10T19:45:38.668599",
      "source_database": "PubMed",
      "research_goal": "GABA-A Receptor Subtype-Selective Agonist Development",
      "added_to_database": "2025-11-10T19:45:38.668601"
    },
    {
      "article_id": "ART-00006",
      "title": "Mescaline: A Global History of the First Psychedelic",
      "authors": [
        "Jay M"
      ],
      "doi": "10.1080/02791072.2019.1606472",
      "pmid": null,
      "journal": "Journal of Psychoactive Drugs",
      "year": 2019,
      "abstract": null,
      "url": null,
      "keywords": [
        "mescaline",
        "psychedelic",
        "5-HT2A",
        "history",
        "peyote"
      ],
      "relevance_score": 85.0,
      "scan_date": "2025-11-10T19:45:38.668605",
      "source_database": "PubMed",
      "research_goal": "Psychedelic Analog Development for Depression and Addiction",
      "added_to_database": "2025-11-10T19:45:38.668606"
    },
    {
      "article_id": "ART-00007",
      "title": "Structure of a Hallucinogen-Activated Gq-Coupled 5-HT(2A) Serotonin Receptor.",
      "authors": [
        "Kim K",
        "Che T",
        "Panova O",
        "DiBerto JF",
        "Lyu J"
      ],
      "doi": "10.1016/j.cell.2020.08.024",
      "pmid": "32946782",
      "journal": "Cell",
      "year": 2020,
      "abstract": null,
      "url": null,
      "keywords": [],
      "relevance_score": 85.0,
      "scan_date": "2025-11-10T19:47:40.993593",
      "source_database": "PubMed",
      "research_goal": "psilocybin 5-HT2A receptor depression treatment",
      "added_to_database": "2025-11-10T19:47:40.993612"
    },
    {
      "article_id": "ART-00008",
      "title": "Increased global integration in the brain after psilocybin therapy for depression.",
      "authors": [
        "Daws RE",
        "Timmermann C",
        "Giribaldi B",
        "Sexton JD",
        "Wall MB"
      ],
      "doi": "10.1038/s41591-022-01744-z",
      "pmid": "35411074",
      "journal": "Nature medicine",
      "year": 2022,
      "abstract": null,
      "url": null,
      "keywords": [],
      "relevance_score": 85.0,
      "scan_date": "2025-11-10T19:47:40.993623",
      "source_database": "PubMed",
      "research_goal": "psilocybin 5-HT2A receptor depression treatment",
      "added_to_database": "2025-11-10T19:47:40.993624"
    },
    {
      "article_id": "ART-00009",
      "title": "Serotonin 2A Receptor (5-HT(2A)R) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants.",
      "authors": [
        "Duan W",
        "Cao D",
        "Wang S",
        "Cheng J"
      ],
      "doi": "10.1021/acs.chemrev.3c00375",
      "pmid": "38033123",
      "journal": "Chemical reviews",
      "year": 2024,
      "abstract": null,
      "url": null,
      "keywords": [],
      "relevance_score": 85.0,
      "scan_date": "2025-11-10T19:47:40.993630",
      "source_database": "PubMed",
      "research_goal": "psilocybin 5-HT2A receptor depression treatment",
      "added_to_database": "2025-11-10T19:47:40.993632"
    },
    {
      "article_id": "ART-00010",
      "title": "Molecular mechanisms of rapid-acting antidepressants: New perspectives for developing antidepressants.",
      "authors": [
        "Chen T",
        "Cheng L",
        "Ma J",
        "Yuan J",
        "Pi C"
      ],
      "doi": "10.1016/j.phrs.2023.106837",
      "pmid": "37379962",
      "journal": "Pharmacological research",
      "year": 2023,
      "abstract": null,
      "url": null,
      "keywords": [],
      "relevance_score": 85.0,
      "scan_date": "2025-11-10T19:47:40.993638",
      "source_database": "PubMed",
      "research_goal": "psilocybin 5-HT2A receptor depression treatment",
      "added_to_database": "2025-11-10T19:47:40.993639"
    },
    {
      "article_id": "ART-00011",
      "title": "Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.",
      "authors": [
        "Madsen MK",
        "Fisher PM",
        "Burmester D",
        "Dyssegaard A",
        "Stenb\u00e6k DS"
      ],
      "doi": "10.1038/s41386-019-0324-9",
      "pmid": "30685771",
      "journal": "Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology",
      "year": 2019,
      "abstract": null,
      "url": null,
      "keywords": [],
      "relevance_score": 85.0,
      "scan_date": "2025-11-10T19:47:40.993645",
      "source_database": "PubMed",
      "research_goal": "psilocybin 5-HT2A receptor depression treatment",
      "added_to_database": "2025-11-10T19:47:40.993647"
    },
    {
      "article_id": "ART-00012",
      "title": "mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.",
      "authors": [
        "Li N",
        "Lee B",
        "Liu RJ",
        "Banasr M",
        "Dwyer JM"
      ],
      "doi": "10.1126/science.1190287",
      "pmid": "20724638",
      "journal": "Science (New York, N.Y.)",
      "year": 2010,
      "abstract": null,
      "url": null,
      "keywords": [],
      "relevance_score": 85.0,
      "scan_date": "2025-11-10T19:47:44.245149",
      "source_database": "PubMed",
      "research_goal": "ketamine NMDA antagonist rapid antidepressant",
      "added_to_database": "2025-11-10T19:47:44.245165"
    },
    {
      "article_id": "ART-00013",
      "title": "NMDA Receptor Activation-Dependent Antidepressant-Relevant Behavioral and Synaptic Actions of Ketamine.",
      "authors": [
        "Zanos P",
        "Brown KA",
        "Georgiou P",
        "Yuan P",
        "Zarate CA Jr"
      ],
      "doi": "10.1523/JNEUROSCI.1316-22.2022",
      "pmid": "36596696",
      "journal": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
      "year": 2023,
      "abstract": null,
      "url": null,
      "keywords": [],
      "relevance_score": 85.0,
      "scan_date": "2025-11-10T19:47:44.245180",
      "source_database": "PubMed",
      "research_goal": "ketamine NMDA antagonist rapid antidepressant",
      "added_to_database": "2025-11-10T19:47:44.245181"
    },
    {
      "article_id": "ART-00014",
      "title": "Ketamine for depression.",
      "authors": [
        "Jelen LA",
        "Stone JM"
      ],
      "doi": "10.1080/09540261.2020.1854194",
      "pmid": "33569971",
      "journal": "International review of psychiatry (Abingdon, England)",
      "year": 2021,
      "abstract": null,
      "url": null,
      "keywords": [],
      "relevance_score": 85.0,
      "scan_date": "2025-11-10T19:47:44.245191",
      "source_database": "PubMed",
      "research_goal": "ketamine NMDA antagonist rapid antidepressant",
      "added_to_database": "2025-11-10T19:47:44.245193"
    },
    {
      "article_id": "ART-00015",
      "title": "Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatments.",
      "authors": [
        "Krystal JH",
        "Kaye AP",
        "Jefferson S",
        "Girgenti MJ",
        "Wilkinson ST"
      ],
      "doi": "10.1073/pnas.2305772120",
      "pmid": "38011560",
      "journal": "Proceedings of the National Academy of Sciences of the United States of America",
      "year": 2023,
      "abstract": null,
      "url": null,
      "keywords": [],
      "relevance_score": 85.0,
      "scan_date": "2025-11-10T19:47:44.245199",
      "source_database": "PubMed",
      "research_goal": "ketamine NMDA antagonist rapid antidepressant",
      "added_to_database": "2025-11-10T19:47:44.245200"
    },
    {
      "article_id": "ART-00016",
      "title": "NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.",
      "authors": [
        "Autry AE",
        "Adachi M",
        "Nosyreva E",
        "Na ES",
        "Los MF"
      ],
      "doi": "10.1038/nature10130",
      "pmid": "21677641",
      "journal": "Nature",
      "year": 2011,
      "abstract": null,
      "url": null,
      "keywords": [],
      "relevance_score": 85.0,
      "scan_date": "2025-11-10T19:47:44.245206",
      "source_database": "PubMed",
      "research_goal": "ketamine NMDA antagonist rapid antidepressant",
      "added_to_database": "2025-11-10T19:47:44.245207"
    },
    {
      "article_id": "ART-00017",
      "title": "MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?",
      "authors": [
        "Feduccia AA",
        "Mithoefer MC"
      ],
      "doi": "10.1016/j.pnpbp.2018.03.003",
      "pmid": "29524515",
      "journal": "Progress in neuro-psychopharmacology & biological psychiatry",
      "year": 2018,
      "abstract": null,
      "url": null,
      "keywords": [],
      "relevance_score": 85.0,
      "scan_date": "2025-11-10T19:47:47.450379",
      "source_database": "PubMed",
      "research_goal": "MDMA PTSD therapy serotonin oxytocin",
      "added_to_database": "2025-11-10T19:47:47.450400"
    },
    {
      "article_id": "ART-00018",
      "title": "MDMA-Based Psychotherapy in Treatment-Resistant Post-Traumatic Stress Disorder (PTSD): A Brief Narrative Overview of Current Evidence.",
      "authors": [
        "Riaz K",
        "Suneel S",
        "Hamza Bin Abdul Malik M",
        "Kashif T",
        "Ullah I"
      ],
      "doi": "10.3390/diseases11040159",
      "pmid": "37987270",
      "journal": "Diseases (Basel, Switzerland)",
      "year": 2023,
      "abstract": null,
      "url": null,
      "keywords": [],
      "relevance_score": 85.0,
      "scan_date": "2025-11-10T19:47:47.450410",
      "source_database": "PubMed",
      "research_goal": "MDMA PTSD therapy serotonin oxytocin",
      "added_to_database": "2025-11-10T19:47:47.450411"
    },
    {
      "article_id": "ART-00019",
      "title": "The potential dangers of using MDMA for psychotherapy.",
      "authors": [
        "Parrott AC"
      ],
      "doi": "10.1080/02791072.2014.873690",
      "pmid": "24830184",
      "journal": "Journal of psychoactive drugs",
      "year": 2014,
      "abstract": null,
      "url": null,
      "keywords": [],
      "relevance_score": 85.0,
      "scan_date": "2025-11-10T19:47:47.450417",
      "source_database": "PubMed",
      "research_goal": "MDMA PTSD therapy serotonin oxytocin",
      "added_to_database": "2025-11-10T19:47:47.450419"
    },
    {
      "article_id": "ART-00020",
      "title": "3,4-methylenedioxymethamphetamine (MDMA): current perspectives.",
      "authors": [
        "Meyer JS"
      ],
      "doi": "10.2147/SAR.S37258",
      "pmid": "24648791",
      "journal": "Substance abuse and rehabilitation",
      "year": 2013,
      "abstract": null,
      "url": null,
      "keywords": [],
      "relevance_score": 85.0,
      "scan_date": "2025-11-10T19:47:47.450424",
      "source_database": "PubMed",
      "research_goal": "MDMA PTSD therapy serotonin oxytocin",
      "added_to_database": "2025-11-10T19:47:47.450426"
    },
    {
      "article_id": "ART-00021",
      "title": "A Neuroanatomic and Pathophysiologic Framework for Novel Pharmacological Approaches to the Treatment of Post-traumatic Stress Disorder.",
      "authors": [
        "Norred MA",
        "Zuschlag ZD",
        "Hamner MB"
      ],
      "doi": "10.1007/s40265-023-01983-5",
      "pmid": "38413493",
      "journal": "Drugs",
      "year": 2024,
      "abstract": null,
      "url": null,
      "keywords": [],
      "relevance_score": 85.0,
      "scan_date": "2025-11-10T19:47:47.450431",
      "source_database": "PubMed",
      "research_goal": "MDMA PTSD therapy serotonin oxytocin",
      "added_to_database": "2025-11-10T19:47:47.450432"
    },
    {
      "article_id": "ART-00022",
      "title": "A Method to Quantify Drosophila Behavioral Activities Induced by GABA(A) Agonist Muscimol.",
      "authors": [
        "Karim MR"
      ],
      "doi": "10.21769/BioProtoc.3982",
      "pmid": "34124286",
      "journal": "Bio-protocol",
      "year": 2021,
      "abstract": null,
      "url": null,
      "keywords": [],
      "relevance_score": 85.0,
      "scan_date": "2025-11-10T19:47:52.332718",
      "source_database": "PubMed",
      "research_goal": "muscimol GABA-A agonist sleep anxiety",
      "added_to_database": "2025-11-10T19:47:52.332740"
    },
    {
      "article_id": "ART-00023",
      "title": "GABA(A) agonists and partial agonists: THIP (Gaboxadol) as a non-opioid analgesic and a novel type of hypnotic.",
      "authors": [
        "Krogsgaard-Larsen P",
        "Fr\u00f8lund B",
        "Liljefors T",
        "Ebert B"
      ],
      "doi": "10.1016/j.bcp.2004.06.040",
      "pmid": "15451401",
      "journal": "Biochemical pharmacology",
      "year": 2004,
      "abstract": null,
      "url": null,
      "keywords": [],
      "relevance_score": 85.0,
      "scan_date": "2025-11-10T19:47:52.332749",
      "source_database": "PubMed",
      "research_goal": "muscimol GABA-A agonist sleep anxiety",
      "added_to_database": "2025-11-10T19:47:52.332750"
    },
    {
      "article_id": "ART-00024",
      "title": "Feeding behavior elicited by mu opioid and GABA receptor activation in the lateral septum.",
      "authors": [
        "Calderwood MT",
        "Tseng A",
        "Gabriella I",
        "Stanley BG"
      ],
      "doi": "10.1016/j.pbb.2022.173395",
      "pmid": "35513120",
      "journal": "Pharmacology, biochemistry, and behavior",
      "year": 2022,
      "abstract": null,
      "url": null,
      "keywords": [],
      "relevance_score": 85.0,
      "scan_date": "2025-11-10T19:47:52.332756",
      "source_database": "PubMed",
      "research_goal": "muscimol GABA-A agonist sleep anxiety",
      "added_to_database": "2025-11-10T19:47:52.332758"
    },
    {
      "article_id": "ART-00025",
      "title": "[Implications of GABAergic synapses in neuropsychiatry].",
      "authors": [
        "Lloyd KG",
        "Perrault G",
        "Zivkovic B"
      ],
      "doi": null,
      "pmid": "2867252",
      "journal": "Journal de pharmacologie",
      "year": 1985,
      "abstract": null,
      "url": null,
      "keywords": [],
      "relevance_score": 85.0,
      "scan_date": "2025-11-10T19:47:52.332763",
      "source_database": "PubMed",
      "research_goal": "muscimol GABA-A agonist sleep anxiety",
      "added_to_database": "2025-11-10T19:47:52.332765"
    },
    {
      "article_id": "ART-00026",
      "title": "GABA(A) receptor modulation of 5-HT neuronal firing in the median raphe nucleus: implications for the action of anxiolytics.",
      "authors": [
        "Judge SJ",
        "Young RL",
        "Gartside SE"
      ],
      "doi": "10.1016/j.euroneuro.2006.01.010",
      "pmid": "16531019",
      "journal": "European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology",
      "year": 2006,
      "abstract": null,
      "url": null,
      "keywords": [],
      "relevance_score": 85.0,
      "scan_date": "2025-11-10T19:47:52.332771",
      "source_database": "PubMed",
      "research_goal": "muscimol GABA-A agonist sleep anxiety",
      "added_to_database": "2025-11-10T19:47:52.332772"
    }
  ]
}